U.S. flag An official website of the United States government
  1. Home
  2. Regulatory Information
  3. Search for FDA Guidance Documents
  4. CVM GFI #265 Use of Data from Foreign Investigational Studies to Support Effectiveness of New Animal Drugs
  1. Search for FDA Guidance Documents

GUIDANCE DOCUMENT

CVM GFI #265 Use of Data from Foreign Investigational Studies to Support Effectiveness of New Animal Drugs July 2020

Draft

Not for implementation. Contains non-binding recommendations.

Docket Number:
FDA-2020-D-1396
Issued by:
Guidance Issuing Office
Center for Veterinary Medicine

This guidance describes principles for designing, conducting, and reporting the results for investigations or studies, including data from foreign countries, in submissions to CVM to demonstrate substantial evidence of effectiveness for new animal drug applications or a reasonable expectation of effectiveness for applications for conditional approval of a new animal drug.  It also describes how sponsors may obtain feedback from CVM regarding the incorporation of data from foreign countries into investigations and study protocols before the submission of an application.  FDA is committed to supporting data that may be recognized globally in order to enhance animal drug development, facilitate the use of foreign data, and minimize the need to conduct duplicative studies. 


Submit Comments

You can submit online or written comments on any guidance at any time (see 21 CFR 10.115(g)(5))

If unable to submit comments online, please mail written comments to:

Dockets Management
Food and Drug Administration
5630 Fishers Lane, Rm 1061
Rockville, MD 20852

All written comments should be identified with this document's docket number: FDA-2020-D-1396.

Questions?

Contact Point
Susan Storey
Center for Veterinary Medicine
Food and Drug Administration
7500 Standish Place, HFV-131
Rockville, MD 20855
Back to Top